Mari Kamiya

462 total citations
17 papers, 193 citations indexed

About

Mari Kamiya is a scholar working on Rheumatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Mari Kamiya has authored 17 papers receiving a total of 193 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Mari Kamiya's work include Systemic Lupus Erythematosus Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Mari Kamiya is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Inflammatory Myopathies and Dermatomyositis (4 papers). Mari Kamiya collaborates with scholars based in Japan, Australia and Brazil. Mari Kamiya's co-authors include Fumitaka Mizoguchi, Shinsuke Yasuda, Hitoshi Kohsaka, Kimito Kawahata, Masahiro Nishibori, Jessica Day, Cynthia Louis, Ian P. Wicks, Dengli Wang and Nobuyuki Miyasaka and has published in prestigious journals such as Cell, Nature Communications and Frontiers in Immunology.

In The Last Decade

Mari Kamiya

16 papers receiving 192 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mari Kamiya Japan 7 65 52 43 38 36 17 193
Femke Bonte‐Mineur Netherlands 10 45 0.7× 55 1.1× 40 0.9× 52 1.4× 53 1.5× 12 235
Pancy O. S. Tam Hong Kong 13 90 1.4× 70 1.3× 56 1.3× 31 0.8× 69 1.9× 21 419
Hui‐Ching Hsu Taiwan 11 57 0.9× 53 1.0× 55 1.3× 27 0.7× 19 0.5× 30 250
Yonatan Edel Israel 10 116 1.8× 30 0.6× 14 0.3× 38 1.0× 18 0.5× 27 237
Erin Naismith Austria 9 69 1.1× 18 0.3× 54 1.3× 38 1.0× 165 4.6× 11 336
Jorge A. Irizarry‐Caro United States 6 73 1.1× 21 0.4× 14 0.3× 39 1.0× 82 2.3× 16 209
А. С. Авдеева Russia 9 66 1.0× 186 3.6× 25 0.6× 15 0.4× 70 1.9× 69 274
Allyson K. Bloom United States 5 62 1.0× 68 1.3× 113 2.6× 16 0.4× 18 0.5× 6 327
Xue‐Zhen Liang China 9 89 1.4× 27 0.5× 15 0.3× 11 0.3× 15 0.4× 29 229
Iwona Kobielusz‐Gembala Poland 5 23 0.4× 23 0.4× 42 1.0× 15 0.4× 54 1.5× 9 143

Countries citing papers authored by Mari Kamiya

Since Specialization
Citations

This map shows the geographic impact of Mari Kamiya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Kamiya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Kamiya more than expected).

Fields of papers citing papers by Mari Kamiya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari Kamiya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Kamiya. The network helps show where Mari Kamiya may publish in the future.

Co-authorship network of co-authors of Mari Kamiya

This figure shows the co-authorship network connecting the top 25 collaborators of Mari Kamiya. A scholar is included among the top collaborators of Mari Kamiya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari Kamiya. Mari Kamiya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Sugihara, Takahiko, Hiroyuki Baba, Tadashi Hosoya, et al.. (2025). Long-term outcome of a treat-to-target strategy in late-onset rheumatoid arthritis with chronic lung disease: 5-year results of a prospective observational study. Arthritis Research & Therapy. 27(1). 22–22. 2 indexed citations
3.
Kamiya, Mari, Hideyuki Iwai, Yoshio Suzuki, et al.. (2024). Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167472–167472. 4 indexed citations
4.
Kamiya, Mari, Milena S. Espíndola, Tracy J. Doyle, et al.. (2024). Immune mechanisms in fibrotic interstitial lung disease. Cell. 187(14). 3506–3530. 31 indexed citations
5.
Sugihara, Takahiko, Tatsuro Ishizaki, Tadashi Hosoya, et al.. (2023). AB0219 LONG-TERM OUTCOMES OF METHOTREXATE IN ELDERLY-ONSET RA IMPLEMENTING THE TREAT-TO-TARGET STRATEGY. Annals of the Rheumatic Diseases. 82. 1293–1294. 1 indexed citations
6.
Matsumoto, T., Takahiko Sugihara, Tadashi Hosoya, et al.. (2023). Effectiveness and safety of treat-to-target strategy for methotrexate-naïve rheumatoid arthritis patients >75 years of age. Rheumatology Advances in Practice. 8(1). rkae019–rkae019. 3 indexed citations
7.
Kamiya, Mari, et al.. (2023). Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy. Frontiers in Immunology. 14. 1191815–1191815. 6 indexed citations
8.
Kamiya, Mari, Fumitaka Mizoguchi, Kimito Kawahata, et al.. (2022). Targeting necroptosis in muscle fibers ameliorates inflammatory myopathies. Nature Communications. 13(1). 166–166. 49 indexed citations
9.
Hasegawa, Hisanori, et al.. (2022). Refractory antiphospholipid antibody syndrome–induced thrombocytopaenia successfully treated with belimumab. Lupus. 31(5). 624–627. 5 indexed citations
10.
Sugihara, Takahiko, Fumio Hirano, T. Matsumoto, et al.. (2022). Factors associated with impaired physical function in elderly rheumatoid arthritis patients who had achieved low disease activity. Modern Rheumatology. 34(1). 60–67. 4 indexed citations
11.
Kamiya, Mari, Fumitaka Mizoguchi, & Shinsuke Yasuda. (2022). Amelioration of inflammatory myopathies by glucagon‐like peptide‐1 receptor agonist via suppressing muscle fibre necroptosis. Journal of Cachexia Sarcopenia and Muscle. 13(4). 2118–2131. 30 indexed citations
12.
Sugihara, Takahiko, Tatsuro Ishizaki, Hiroyuki Baba, et al.. (2020). Effectiveness and safety of treat-to-target strategy in elderly-onset rheumatoid arthritis: a 3-year prospective observational study. Lara D. Veeken. 60(9). 4252–4261. 28 indexed citations
13.
Kamiya, Mari, Fumitaka Mizoguchi, Akito Takamura, et al.. (2019). A new in vitro model of polymyositis reveals CD8+ T cell invasion into muscle cells and its cytotoxic role. Lara D. Veeken. 59(1). 224–232. 16 indexed citations
14.
Ota, Mineto, et al.. (2016). Acute Tubulointerstitial Nephritis Associated with Infliximab in a Patient with Crohn's Disease. Internal Medicine. 55(10). 1367–1370. 6 indexed citations
15.
Kamiya, Mari, et al.. (2016). Allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis under adalimumab therapy: a case report. Japanese Journal of Clinical Immunology. 39(1). 84–89. 3 indexed citations
16.
Kamiya, Mari, et al.. (2016). IgG4-Related Sialoadenitis with a Skin Lesion and Multiple Mononeuropathies Suggesting Coexistent Cryoglobulinemic Vasculitis. Internal Medicine. 55(10). 1355–1361. 3 indexed citations
17.
Ishizuka, Hiroki, et al.. (2006). Collecting Adaptive Data for Isolated Wireless Sensors with Patrol Nodes in Live E!. 136–136. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Femke Bonte‐Mineur Breakdown of academic impact, for papers by Pancy O. S. Tam Breakdown of academic impact, for papers by Hui‐Ching Hsu Breakdown of academic impact, for papers by Yonatan Edel Breakdown of academic impact, for papers by Erin Naismith Breakdown of academic impact, for papers by Jorge A. Irizarry‐Caro Breakdown of academic impact, for papers by А. С. Авдеева Breakdown of academic impact, for papers by Allyson K. Bloom Breakdown of academic impact, for papers by Xue‐Zhen Liang Breakdown of academic impact, for papers by Iwona Kobielusz‐Gembala
Rankless by CCL
2026